On May 13, 1992, the U.S. Congress announced the Generic Drug Enforcement Act, sponsored by Rep. John Dingell [D-MI], imposed debarment and other penalties for illegal acts involving any abbreviated drug application (ADA) be debarred from submitting, or assisting in the submission of, any ADA.